Navellier & Associates’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-140,523
Closed -$2.82M 271
2022
Q4
$2.82M Buy
140,523
+3,090
+2% +$66.1K 0.58% 62
2022
Q3
$1.94M Buy
137,433
+6,107
+5% +$82.2K 0.43% 75
2022
Q2
$985K Sell
131,326
-2,967
-2% -$24.6K 0.21% 112
2022
Q1
$1.36M Buy
134,293
+68,610
+104% +$877K 0.23% 106
2021
Q4
$1.59M Buy
+65,683
New +$1.28M 0.23% 107

Other funds holding AEHR

Navellier & Associates's AEHR Position: Q1 2023 in Review

Navellier & Associates sold out of Aehr Test Systems (AEHR) in Q1 2023, closing a stake of 140,523 shares — an estimated $2.82M sold.

Navellier & Associates first reported a position in AEHR in Q4 2021 and held it in 5 quarters. The position peaked at $2.82M in Q4 2022. 144 funds tracked by Wall St. Rank hold AEHR as of Q1 2023.

  • Navellier & Associates reported no remaining Aehr Test Systems position as of Q1 2023 after selling out during the quarter.
  • Navellier & Associates sold 140,523 Aehr Test Systems shares in Q1 2023, an estimated $2.82M.
  • Navellier & Associates first reported a position in Aehr Test Systems in Q4 2021 and held it in 5 quarters.
  • Navellier & Associates's Aehr Test Systems position peaked at $2.82M in Q4 2022.
  • 144 funds tracked by Wall St. Rank held Aehr Test Systems as of Q1 2023.

Based on Navellier & Associates's 13F filing for Q1 2023, filed 12 May 2023.